Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Operating Leases (2020 - 2025)

Mainz Biomed's Operating Leases history spans 5 years, with the latest figure at $865982.0 for Q4 2024.

  • For Q4 2024, Operating Leases fell 25.71% year-over-year to $865982.0; the TTM value through Dec 2024 reached $865982.0, down 25.71%, while the annual FY2024 figure was $865982.0, 25.71% down from the prior year.
  • Operating Leases for Q4 2024 was $865982.0 at Mainz Biomed, down from $1.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $1.2 million in Q4 2023 and bottomed at $387766.0 in Q4 2021.
  • The 5-year median for Operating Leases is $865982.0 (2024), against an average of $774727.6.
  • The largest annual shift saw Operating Leases soared 147.34% in 2022 before it decreased 25.71% in 2024.
  • A 5-year view of Operating Leases shows it stood at $495051.0 in 2020, then dropped by 21.67% to $387766.0 in 2021, then skyrocketed by 147.34% to $959116.0 in 2022, then increased by 21.54% to $1.2 million in 2023, then fell by 25.71% to $865982.0 in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Operating Leases are $865982.0 (Q4 2024), $1.2 million (Q4 2023), and $959116.0 (Q4 2022).